|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Zimmermann, Heiner; Koenecke, Christian; Dreyling, Martin H.; Pott, Christiane; Duehrsen, Ulrich; Hahn, Dennis; Meidenbauer, Norbert; Hauser, Ingeborg A.; Rummel, Mathias J.; Wolf, Dominik; Heuser, Michael; Schmidt, Christian; Schlattmann, Peter; Ritgen, Matthias; Siebert, Reiner; Oschlies, Ilske; Anagnostopoulos, Ioannis und Trappe, Ralf U.
(2022):
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
In: Leukemia, Bd. 36, Nr. 10: S. 2468-2478
Borchmann, Peter; Haverkamp, Heinz; Lohri, Andreas; Mey, Ulrich; Kreissl, Stefanie; Greil, Richard; Markova, Jana; Feuring-Buske, Michaela; Meissner, Julia; Duehrsen, Ulrich; Ostermann, Helmut; Keller, Ulrich; Maschmeyer, Georg; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Diehl, Volker und Engert, Andreas
(2017):
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
In: Lancet Oncology, Bd. 18, Nr. 4: S. 454-463